Neurogene
Anandita Seth has extensive work experience in the biotechnology and pharmaceutical industry. Anandita is currently working at Neurogene Inc. as the Vice President of Process and Analytical Development since April 2022. Prior to this, they worked at Neurogene Inc. as the Executive Director of Product Development and Operations from January 2020 to April 2022.
Before joining Neurogene Inc., Anandita worked at Lonza, where they held the position of Head of Research & Technology, Viral Therapy from September 2016 to January 2020. Prior to that, they worked as a Process Development Scientist at Lonza from October 2012 to October 2016.
Anandita's earlier experience includes working as a Senior Research Scientist at Stem Cell Innovations from June 2007 to October 2012, and as a Post-doc at Emory University from September 2005 to May 2007. Anandita also worked as a PhD student at the University of Massachusetts, Amherst from September 2000 to September 2005.
Anandita Seth pursued their education in the field of Molecular and Cell Biology at the University of Massachusetts Amherst. Anandita completed their PhD program from 2000 to 2005.
This person is not in any offices
Neurogene
Neurogene was founded to bring life-changing medicines to patients and families affected by rare neurological disorders. We partner with leading academic researchers, patient advocacy organizations and caregivers to bring to patients therapies that address the underlying genetic cause of a broad spectrum of neurological diseases where no effective treatment options exist today. Our lead programs use AAV-based gene therapy technology to deliver a normal gene to patients with a dysfunctional gene. Neurogene is also investing in novel technology to develop treatments for diseases not well served by gene therapy.